We have made giant leaps in drug discovery over the past 10 years. However, the bioproduction industry cannot keep up. Complex proteins are challenging to produce at high yields and in a reliable fashion, and in order to reap the rewards of recent advances in drug discovery a bioproduction revolution is needed.
kyron.bio is building the bioproduction platform of the future by harnessing highly efficient processes from diverse organisms and genetically engineering them into existing bioproduction platforms. Our patentable technology boosts both the effectiveness and yield of therapeutic proteins produced in mammalian cell factories. We are guided by leaders from GSK, Sanofi and Bayer.
kyron.bio’s mission is to help bring better, cheaper and novel biopharmaceuticals to market.
